Insider Transactions in Q2 2021 at Albireo Pharma, Inc. (ALBO)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 25
2021
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
471
-1.75%
|
$16,956
$36.01 P/Share
|
Jun 25
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
6,300
-44.12%
|
$226,800
$36.22 P/Share
|
Jun 25
2021
|
Jason Duncan Chief Legal Officer and GC |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+30.61%
|
$151,200
$24.67 P/Share
|
Jun 24
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
10,000
-55.62%
|
$360,000
$36.38 P/Share
|
Jun 24
2021
|
Jason Duncan Chief Legal Officer and GC |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.69%
|
$240,000
$24.36 P/Share
|
Apr 23
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
222
-2.75%
|
$7,104
$32.32 P/Share
|
Apr 22
2021
|
Patrick Taylor Horn Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
90
-0.75%
|
$2,790
$31.75 P/Share
|
Apr 22
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
90
-1.1%
|
$2,790
$31.75 P/Share
|
Apr 12
2021
|
Simon N.R. Harford CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
92
-0.75%
|
$2,944
$32.12 P/Share
|
Apr 01
2021
|
Jason Duncan Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct |
300
-3.55%
|
$10,800
$36.16 P/Share
|
Apr 01
2021
|
Jason Duncan Chief Legal Officer and GC |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+3.42%
|
$7,200
$24.04 P/Share
|